Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BY 4.0Journal of Clinical Medicine

The Clinical Phenotype of Green Pit Viper (Trimeresurus spp.) Envenomation: A Comprehensive Review

7 affiliations
  1. 1Dermatology Unit, Università Vita-Salute San Raffaele, 20132 Milan, Italy
  2. 2Dermatology Clinic, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy
  3. 3Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, 10154 Turin, Italy
  4. 4Dermatology Unit, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, 21100 Varese, Italy
  5. 5Section of Dermatology and Venereology, Department of Medicine, University of Verona, 37126 Verona, Italy
  6. 6Department of Medicine and Innovation Technology (DiMIT), University of Insubria, 21100 Varese, Italy
  7. 7Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy

Abstract

Green pit vipers of the genus Trimeresurus are among the leading causes of snakebite envenomation across tropical and subtropical Asia, yet their clinical phenotype has been less systematically characterized than that of other medically important Asian viperids. This comprehensive review synthesizes the published clinical literature on human Trimeresurus envenomation, drawing on 70 clinical reports encompassing 4720 reported patient episodes, and integrates these data with current taxonomic and venomic evidence. Envenomations cluster in East, Southeast, and South Asia. The single most important limitation of this literature is the unreliability of species attribution: 55% of reported cases are attributed only at genus level or derive from cohorts in which two or more Trimeresurus species are reported together and cannot be separated, a figure consistent with the 56% of snakebites left unidentified in a recent 40,817-patient Chinese survey. Bites involve the extremities almost exclusively, with a predominance of the lower limb (55% versus 45%). The clinical picture is dominated by local effects (i.e., extensive edema and pain in the large majority of patients, secondary infection in approximately one in six, and cutaneous necrosis in approximately one in thirty) and by systemic hemotoxicity driven by venom-induced consumptive coagulopathy. Renal involvement is uncommon, in contrast to Daboia russelii envenomation, and severe neurotoxicity is exceptional. Documented mortality in the reviewed hospital-based literature is low (two deaths among 3387 patients in reports documenting outcome, <0.1%) but is not zero, and hospital-based series cannot capture pre-hospital deaths. Management centers on conservative wound care, serial coagulation monitoring, and selective antivenom administration; routine fasciotomy is not justified without objective evidence of compartment syndrome. Reliable species identification, standardized clinical reporting, and long-term functional follow-up remain the principal unmet needs.

Related

  1. Commentary: Efgartigimod for generalized myasthenia gravis: a comprehensive review of clinical evidence and future perspectives
    Ana Belén Fernández
    Frontiers in NeurologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefPMC
  2. Machine Learning and Deep Learning for Early Disease Detection Across Modalities: A Comprehensive Review of Methods, Applications, and Clinical Translation
    Ahlem Aziz, Seydi Kacmaz, Azam Isam Abdulkareem Aladwani
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. The Clinical and Diagnostic Spectrum of Esophagitis Dissecans Superficialis: A Comprehensive Retrospective Case Series and Literature Review
    Btissam Essâdi, Ayoub Bouziane, Ouiam Elmqaddam +4
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Pulsed Low-Dose-Rate Radiotherapy (PLDR): A Comprehensive Review of Radiobiological Rationale and Clinical Applications in Modern Cancer Care
    James S Welsh, Seyed Alireza Javadinia, Veronia Fahmy +4
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Artificial intelligence for full-cycle clinical management in orthokeratology: a comprehensive review
    Xiaotong Wang, Haojiang Yang
    Frontiers in MedicinePeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMCEurope PMC
BibTeX
@article{paolino2026clinical,
  title = {{The Clinical Phenotype of Green Pit Viper (Trimeresurus spp.) Envenomation: A Comprehensive Review}},
  author = {Giovanni Paolino and Matteo Riccardo Di Nicola and Rachele Bardelli and Noemi Brigenti and Nicola Zerbinati and Santo Raffaele Mercuri and Andrea Carugno},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  month = nov,
  doi = {10.3390/jcm15218569},
  url = {https://www.mdpi.com/2077-0383/15/21/8569},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The Clinical Phenotype of Green Pit Viper (Trimeresurus spp.) Envenomation: A Comprehensive Review
AU  - Giovanni Paolino
AU  - Matteo Riccardo Di Nicola
AU  - Rachele Bardelli
AU  - Noemi Brigenti
AU  - Nicola Zerbinati
AU  - Santo Raffaele Mercuri
AU  - Andrea Carugno
PY  - 2026
DA  - 2026/11/03
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15218569
UR  - https://www.mdpi.com/2077-0383/15/21/8569
AB  - Green pit vipers of the genus Trimeresurus are among the leading causes of snakebite envenomation across tropical and subtropical Asia, yet their clinical phenotype has been less systematically characterized than that of other medically important Asian viperids. This comprehensive review synthesizes the published clinical literature on human Trimeresurus envenomation, drawing on 70 clinical reports encompassing 4720 reported patient episodes, and integrates these data with current taxonomic and venomic evidence. Envenomations cluster in East, Southeast, and South Asia. The single most important limitation of this literature is the unreliability of species attribution: 55% of reported cases are attributed only at genus level or derive from cohorts in which two or more Trimeresurus species are reported together and cannot be separated, a figure consistent with the 56% of snakebites left unidentified in a recent 40,817-patient Chinese survey. Bites involve the extremities almost exclusively, with a predominance of the lower limb (55% versus 45%). The clinical picture is dominated by local effects (i.e., extensive edema and pain in the large majority of patients, secondary infection in approximately one in six, and cutaneous necrosis in approximately one in thirty) and by systemic hemotoxicity driven by venom-induced consumptive coagulopathy. Renal involvement is uncommon, in contrast to Daboia russelii envenomation, and severe neurotoxicity is exceptional. Documented mortality in the reviewed hospital-based literature is low (two deaths among 3387 patients in reports documenting outcome, <0.1%) but is not zero, and hospital-based series cannot capture pre-hospital deaths. Management centers on conservative wound care, serial coagulation monitoring, and selective antivenom administration; routine fasciotomy is not justified without objective evidence of compartment syndrome. Reliable species identification, standardized clinical reporting, and long-term functional follow-up remain the principal unmet needs.
SN  - 2077-0383
ER  -